Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User, and Region - Global Forecast to 2024

Abstract
Apex Market Research has published a new report titled ”Global Neurodiagnostics Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global Neurodiagnostics market is estimated to grow from USD 5.9 billion in 2019 to USD 8.4 billion by 2024, at a CAGR of 7.3%. The report offers in-depth insights, revenue details, and other vital information regarding the global Neurodiagnostics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the Neurodiagnostics market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global Neurodiagnostics market report offers in-depth insights, revenue details, and other vital information regarding the global Neurodiagnostics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of Neurodiagnostics market. The major players operating into Neurodiagnostics Market include: Major players covered include GE Healthcare (US)
Siemens Healthineers (Germany)
Philips Healthcare (Netherlands)
Hitachi
Ltd. (Japan)
Canon
Inc. (Japan)
Lifelines Neuro Company
LLC (US)
Natus Medical Incorporated (US)
Hoffman-La Roche AG (Switzerland)
FUJIFILM Holdings Corporation (Japan)
Mitsar Co.
Ltd. (Russia)
Advanced Brain Monitoring (US)
Thermo Fisher Scientific
Inc. (US)
Bio-Rad Laboratories (US)
QIAGEN N.V. (Netherlands)
Nihon Kohden Corporation (Japan)
ANT Neuro (Netherlands)
Fonar Corporation (US)
Fujirebio (Japan)
DRG Instruments GmbH (Germany)
Tecan Trading AG (Switzerland)
Motion Lab Systems
Inc. (US)
Rigaku Corporation (Japan)
Neusoft Medical Systems Co.
Ltd. (US)
ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US). Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value Value (USD)
Covered Segments Product, condition, end-user, and region
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the Neurodiagnostics market to forecast revenues and analyze trends in each of the following submarkets:

By Product

  • Introduction
  • Diagnostic and Imaging Systems
    • Electroencephalogram (EEG) Systems
    • Electromyography (EMG) Products
    • Magnetic Resonance Imaging (MRI) Systems
    • Ultrasound Imaging Systems
    • Computed Tomography (CT) Scanner
    • Magnetoencephalogram (MEG) System
    • Position emission tomography (PET) System
    • Angiography System
    • Other Systems
  • Clinical Testing Instruments
    • PCR
    • Next-Generation Sequencing (NGS)
    • Sanger Sequencing
    • Other Clinical Diagnostic Products
  • Reagents & Consumables
    • Media and Serra
    • Solvents
    • Enzymes, Protein & Peptides
    • Probes
    • Buffers
    • Antibodies
    • Other Reagents

By Condition

  • Neuro Degenerative Diseases
  • Epilepsy
  • Stroke
  • Headache Disorders
  • Sleep Disorders
  • Other Diseases

By End-User

  • Hospitals and Surgery Centers
  • Neurology Centers
  • Ambulatory Care Centers
  • Diagnostic Laboratories & Imaging Centers
  • Research Laboratories & Academic Institutes
By geography, this market has been segregated into five regions with revenue and growth rate of Neurodiagnostics from 2020 to 2027,
There are 13 chapters to put on view for Neurodiagnostics Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Neurodiagnostics Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Neurodiagnostics Market Overview 1.1.1 Neurodiagnostics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Neurodiagnostics Market Size and Analysis by Regions (2015-2019) 1.2.1 North America Neurodiagnostics Market Status and Outlook 1.2.2 EU Neurodiagnostics Market Status and Outlook 1.2.3 Japan Neurodiagnostics Market Status and Outlook 1.2.4 China Neurodiagnostics Market Status and Outlook 1.2.5 India Neurodiagnostics Market Status and Outlook 1.2.6 Southeast Asia Neurodiagnostics Market Status and Outlook 1.3 Global Neurodiagnostics Market Segment By Product
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast By Country, 2015-2027
1.3.2 Diagnostic and Imaging Systems
1.3.2.1 Electroencephalogram (EEG) Systems
1.3.2.2 Electromyography (EMG) Products
1.3.2.3 Magnetic Resonance Imaging (MRI) Systems
1.3.2.4 Ultrasound Imaging Systems
1.3.2.5 Computed Tomography (CT) Scanner
1.3.2.6 Magnetoencephalogram (MEG) System
1.3.2.7 Position emission tomography (PET) System
1.3.2.8 Angiography System
1.3.2.9 Other Systems
1.3.2.10 Market Estimates And Forecast By Country, 2015-2027
1.3.3 Clinical Testing Instruments
1.3.3.1 PCR
1.3.3.2 Next-Generation Sequencing (NGS)
1.3.3.3 Sanger Sequencing
1.3.3.4 Other Clinical Diagnostic Products
1.3.3.5 Market Estimates And Forecast By Country, 2015-2027
1.3.4 Reagents & Consumables
1.3.4.1 Media and Serra
1.3.4.2 Solvents
1.3.4.3 Enzymes, Protein & Peptides
1.3.4.4 Probes
1.3.4.5 Buffers
1.3.4.6 Antibodies
1.3.4.7 Other Reagents
1.3.4.8 Market Estimates And Forecast By Country, 2015-2027
1.4 Global Neurodiagnostics Market Segment By Condition
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.1 Neuro Degenerative Diseases
1.4.1.1 Market Estimates And Forecast By Country, 2015-2027
1.4.2 Epilepsy
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Stroke
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4.4 Headache Disorders
1.4.4.1 Market Estimates And Forecast By Country, 2015-2027
1.4.5 Sleep Disorders
1.4.5.1 Market Estimates And Forecast By Country, 2015-2027
1.4.6 Other Diseases
1.4.6.1 Market Estimates And Forecast By Country, 2015-2027
1.5 Global Neurodiagnostics Market Segment By End-User
1.5.1 Introduction
1.5.1.1 Market Estimates And Forecast 2015-2027
1.5.1 Hospitals and Surgery Centers
1.5.1.1 Market Estimates And Forecast By Country, 2015-2027
1.5.2 Neurology Centers
1.5.2.1 Market Estimates And Forecast By Country, 2015-2027
1.5.3 Ambulatory Care Centers
1.5.3.1 Market Estimates And Forecast By Country, 2015-2027
1.5.4 Diagnostic Laboratories & Imaging Centers
1.5.4.1 Market Estimates And Forecast By Country, 2015-2027
1.5.5 Research Laboratories & Academic Institutes
1.5.5.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global Neurodiagnostics Competition Analysis by Players 2.1 Global Neurodiagnostics Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Major players covered include GE Healthcare (US) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Major players covered include GE Healthcare (US), Neurodiagnostics Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Siemens Healthineers (Germany) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Siemens Healthineers (Germany), Neurodiagnostics Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 Philips Healthcare (Netherlands) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Philips Healthcare (Netherlands), Neurodiagnostics Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 Hitachi 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Hitachi, Neurodiagnostics Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 Ltd. (Japan) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Ltd. (Japan), Neurodiagnostics Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 Canon 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Canon, Neurodiagnostics Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Inc. (Japan) 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Inc. (Japan), Neurodiagnostics Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 Lifelines Neuro Company 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Lifelines Neuro Company, Neurodiagnostics Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 LLC (US) 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 LLC (US), Neurodiagnostics Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 Natus Medical Incorporated (US) 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Natus Medical Incorporated (US), Neurodiagnostics Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global Neurodiagnostics Market Size Type (2015-2019) 4.1 Global Neurodiagnostics Market Size by Type (2015-2019) Chapter 5 Global Neurodiagnostics Market Size Application (2015-2019) 5.1 Global Neurodiagnostics Market Size by Application (2015-2019) 5.2 Potential Application of Neurodiagnostics in Future 5.3 Top Consumer / End Users of Neurodiagnostics Chapter 6 North America Neurodiagnostics Development Status and Outlook 6.1 North America Neurodiagnostics Market Size (2015-2019) 6.2 North America Neurodiagnostics Market Size by Application (2015-2019) Chapter 7 EU Neurodiagnostics Development Status and Outlook 7.1 EU Neurodiagnostics Market Size (2015-2019) 7.2 EU Neurodiagnostics Market Size by Application (2015-2019) Chapter 8 Japan Neurodiagnostics Development Status and Outlook 8.1 Japan Neurodiagnostics Market Size (2015-2019) 8.2 Japan Neurodiagnostics Market Size by Application (2015-2019) Chapter 9 China Neurodiagnostics Development Status and Outlook 9.1 China Neurodiagnostics Market Size and Forecast (2015-2019) 9.2 China Neurodiagnostics Market Size by Application (2015-2019) Chapter 10 India Neurodiagnostics Development Status and Outlook 10.1 India Neurodiagnostics Market Size and Forecast (2015-2019) 10.2 India Neurodiagnostics Market Size by Application (2015-2019) Chapter 11 Southeast Asia Neurodiagnostics Development Status and Outlook 11.1 Southeast Asia Neurodiagnostics Market Size and Forecast (2015-2019) 11.2 Southeast Asia Neurodiagnostics Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global Neurodiagnostics Market Size (Million USD) by Regions (2020-2027) 12.1. North America Neurodiagnostics Revenue and Growth Rate (2020-2027) 12.1.2 EU Neurodiagnostics Revenue and Growth Rate (2020-2027) 12.1.3 China Neurodiagnostics Revenue and Growth Rate (2020-2027) 12.1.4 Japan Neurodiagnostics Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia Neurodiagnostics Revenue and Growth Rate (2020-2027) 12.1.6 India Neurodiagnostics Revenue and Growth Rate (2020-2027) 12.2 Global Neurodiagnostics Market Size by Application (2020-2027) Chapter 13 Neurodiagnostics Market Dynamics 13.1 Neurodiagnostics Market Opportunities 13.2 Neurodiagnostics Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Neurodiagnostics Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Neurodiagnostics Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1409

4515

OUR CLIENT